Magnetic particles were synthesized with an iron-containing coating. The model drugs were safranin O and hydrocortisone. The particles were functionalized with a bulky azo derivative to act as a gatekeeper and stop early leakage of the drug. In vitro release models have demonstrated that most of the drug is released only in the colon, as desired. This is owing to the reductive environment in the colon (the presence of the azoreductase enzyme), where the enzymatic degradation of the azo bond resulted in controlled release. In addition, in vivo pharmacokinetic studies were conducted in a rat model of induced colitis to test the effect of the magnetic field during therapy. The findings boosted when the rats wore a magnetic belt, which extended the retention time of the particles in the desired areas [ 75 ]. Zhang et al. presented a study in which magnetic silica nanoparticles (filled with sulforaphane) were developed for the treatment of myocardial infarction [ 38 ]. In mouse models, effective accumulation was observed in the infarcted zone after the application of an external magnetic field [ 33, 75 ]. These results show the potential of using magnetic particles with magnetic field guidance [ 33 ]. Radhakrishnan et al. developed a drug delivery system (DDS) loaded with carboplatin for targeted lung cancer therapy [ 63 ]. The DDS was core-shell mesoporous silica functionalized with folic acid. Initially, the drug loading capability of the functionalized carrier was more than twice as high per surface unit compared to the non-functionalized carrier due to the anchored -NH 2 groups. The drug release was sustained but limited (up to 36%) in the case of the functionalized particle, similarly to previous cases. This is most likely owing to the stronger interactions between the amine groups and the carboplatin. The amino-functionalized particles were further functionalized with folic acid to increase cellular uptake of the particles, demonstrating the potential of folic acid-targeted therapy [ 63, 65, 76 ]. Cancer cells typically overexpress folate receptors, resulting in folate-mediated internalization that preferentially targets these cells [ 63, 76 ]. This was demonstrated in a drug-mediated cytotoxicity analysis where amino- and folate-functionalized particles were evaluated and compared. Much greater cytotoxicity was observed in cells overexpressing folate receptors [ 63 ]. Similar research was carried out by Shirani et al., where folic acid functionalized MSNs were loaded with gemcitabine as a model drug, to investigate its potential in cancer treatment, while actively targeting cancer cells [ 70 ]. Outcomes have shown that higher cellular uptake (HeLa and K562 cells) was observed in the case of the functionalized particles, compared with the non-functionalized carriers [ 70 ]. Jafarpour et al. demonstrated the importance of functionalizing the carriers to accomplish targeted therapy utilizing methotrexate as a model drug [ 76 ]. The particles were grafted with a copolymer to act as a pH-responsive gatekeeper and folic acid to actively target cancer cells [ 76 ]. Ortiz et al. similarly designed a pH-responsive DDS, loaded with the anticancer drug doxorubicin [ 11 ]. The particles were functionalized with transferrin through a pH-sensitive linker as a gatekeeper, controlling the release kinetics and preventing early leakage of the drug [ 11 ]. An interesting breast cancer therapy was published by Mal et al. using doxorubicin as API and mesoporous silica as a carrier [ 65 ]. The amine-functionalized MSNs were PEGylated and then conjugated with folic acid or hyaluronic acid. It was also published that coating the nanoparticles with polydopamine (PDA) and polyethylene glycol (PEG) brings about prolonged doxorubicin release from MSNs [ 77 ]. These conjugates enabled ligand-mediated targeted drug delivery [ 65 ]. Researchers have developed a successful DDS that targets cancer cells, thus staying away from the side effects associated with doxorubicin in conventional cancer therapy. This is important because in vitro cytotoxicity studies have shown that the free drug has higher cytotoxicity than the nanocarriers [ 65 ]. Shahbaz et al. developed a redox-responsive silica nanocarrier loaded with paclitaxel to target breast cancer cells [ 67 ]. The amine-functionalized silica core was coated with disulfide-functionalized non-porous silica shell. Then the core-shell carriers were further coated with polyethylene glycol via disulfide linkages. In vitro drug release assay verified the correlation between the redox potential of the environment and the release kinetics. This is an important finding, as it has been revealed that cancer cells possess a higher redox ability than healthy cells. This provides controlled paclitaxel release for targeted therapy. According to cell uptake and cell viability assays, this DDS is noticeably more effective than free paclitaxel, making this nanocarrier an exciting prospect [ 67 ]. These illustrations highlight the importance of surface functionalization and employing stimuli-responsive gatekeepers to attain productive targeted therapy.
What Is Silicon Dioxide (SiO₂)? Structure, Properties, Types and Uses Explained
Fumed Silica 200 m²/g: Properties, Typical Uses and Comparable Grades
Silica as a Reinforcing Agent: How It Improves Strength in Rubber and Polymers
Not certain where to start with diatomaceous earth? The amount of conflicting details about DE can be overwhelming. Find everything you have to be confident in taking your first steps with DE below.
U.S. Silica: Company Overview, Products and Markets Served
Tablets are the most used solid dosage form because of their numerous perks. They are characterized by excellent physical and chemical stability, high patient compliance, and productive economic production [ 92 ]. The incorporation of silica nanocarriers in tablet production presents a modern and innovative solution to diverse hurdles, boosting both the manufacturing process and therapeutic effectiveness. One of the considerable benefits of mesoporous silica carriers is their ability to stabilize the API in an amorphous state, which greatly improves its solubility [ 30, 39, 42, 43, 92 ]. This enhancement brings about a considerable increase in the dissolution rate of tablets, thereby improving bioavailability and resulting in more effective therapy [ 30, 39, 42, 92 ]. Furthermore, nanocarriers can effectively mask the bitter taste and unpleasant odor of the API, potentially further boosting patient compliance [ 42, 93 ]. Zhang et al. observed a considerable improvement in oral bioavailability with Telmisartan-loaded MSN carriers in vivo absorption studies conducted on dogs [ 24 ]. This MSN-containing tablet formulation was compared to commercially available tablets, with notable improvements attributed chiefly to the boosted permeability and solubility provided by the nanocarriers [ 24 ]. Moreover, the physical and chemical stability of the API may also improve, which is especially advantageous for sensitive molecules [ 39, 92 ].
Silica Manufacturers List: Global and Chinese Producers by Product Type
If you're looking to eat DE for the health benefits, we suggest starting with a single teaspoon a day. Simply mix it with a glass of water, juice or a smoothie. After 1 -2 weeks you can build up to a tablespoon a day if you want to grow the effects. Taking DE is generally more effective when done separately from other foods. When taken with food, the absorptive properties of DE are used to take in the nutrients of the food, rather than any toxins in your body. This lessens the effect of both the diatomaceous earth and your meal. The same is true of medications. If you are taking regular medications, we would inspire you to consult with your healthcare provider before taking DE.
Silica Supplier Germany: Leading Producers and Sourcing Considerations
What is silica (SiO₂)?
surface treated silica
67. Shahbaz S., Esmaeili M., Nasab M.H.F., Imani Z., Bafkary R., Amini M., Atyabi F., Dinarvand R. PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells. Int. J. Pharm. 2024;655:124024. doi: 10.1016/j.ijpharm.2024.124024. [ DOI ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica thickener for toothpaste
61. Tzankov B., Voycheva C., Tosheva A., Stefanova D., Tzankova V., Spassova I., Kovacheva D., Avramova K., Tzankova D., Yoncheva K. Novel oleogels for topical delivery of quercetin based on mesoporous silica MCM-41 and HMS particles. J. Drug Deliv. Sci. Technol. 2023;86:104727. doi: 10.1016/j.jddst.2023.104727. [ DOI ] [ Google Scholar ]
What drives silica raw material prices?
silica for sale
The drug loading capacity and the drug release profile for each drug loaded by the solvent immersion approach.
Cite this article: Silica Raw Materials News. "Silica Factory: How Silica Is Produced and What to Check During a Factory Audit
." Published 2026-11-20 02:29:37. /news/article.html Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.